Search results
Found 22581 matches for
A new statement has been released from Professor Peter Horby and Professor Martin Landray, Chief Investigators of the RECOVERY Trial. RECOVERY was established in March as a randomised clinical trial to test a range of potential drugs for COVID-19, including hydroxycholoroquine. The trial has proceeded at unprecedented speed, enrolling over 11,000 patients from 175 NHS hospitals in the UK. The chief investigators have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19.
Savannah Verhage
Savannah Verhage
Virag Heller
Virag Heller - Academic Programmes Assistant - MSc Genomic Medicine
Mike English
- MSc HSIE Lecturers
- MSc IHTM Lecturers
- MSc IHTM steering committee
- Principal Investigators
- Research Scientists
Mike English - Professor of International Child Health
Louise Thwaites
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Professor of Experimental Critical Care
